0001213900-20-027374.txt : 20200918
0001213900-20-027374.hdr.sgml : 20200918
20200918163618
ACCESSION NUMBER: 0001213900-20-027374
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200916
FILED AS OF DATE: 20200918
DATE AS OF CHANGE: 20200918
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LAPOINTE ANTHONY GREGG
CENTRAL INDEX KEY: 0001331860
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14778
FILM NUMBER: 201184361
MAIL ADDRESS:
STREET 1: PO BOX 83216
CITY: GAITHERSBURG
STATE: MD
ZIP: 20883-3216
FORMER NAME:
FORMER CONFORMED NAME: Lapointe Gregg Anthony
DATE OF NAME CHANGE: 20050630
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SOLIGENIX, INC.
CENTRAL INDEX KEY: 0000812796
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 411505029
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE B-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-538-8200
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE B-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: DOR BIOPHARMA INC
DATE OF NAME CHANGE: 20020329
FORMER COMPANY:
FORMER CONFORMED NAME: ENDOREX CORP
DATE OF NAME CHANGE: 19960916
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
OWNERSHIP DOCUMENT
X0306
4
2020-09-16
0
0000812796
SOLIGENIX, INC.
SNGX
0001331860
LAPOINTE ANTHONY GREGG
29 EMMONS DRIVE, SUITE B-10
PRINCETON
NJ
08540
1
0
0
0
Stock Option (Right to Buy)
1.97
2020-09-16
4
A
0
15228
0
A
2030-09-15
Common Stock
15228
15228
D
The stock option vests ratably on each of December 16, 2020, March 16, 2021, June 16, 2021 and September 16, 2021.
/s/ Gregg A. Lapointe
2020-09-18